According to iRadimed's latest financial reports the company's current revenue (TTM) is $65.56 M. In 2022 the company made a revenue of $53.3 M an increase over the years 2021 revenue that were of $41.81 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $65.56 M | 23% |
2022 | $53.3 M | 27.48% |
2021 | $41.81 M | 31.83% |
2020 | $31.71 M | -17.65% |
2019 | $38.51 M | 26.54% |
2018 | $30.43 M | 31.88% |
2017 | $23.08 M | -28.97% |
2016 | $32.49 M | 2.86% |
2015 | $31.59 M | 101.84% |
2014 | $15.65 M | 38.03% |
2013 | $11.34 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | $6.00 B | 9,058.92% | ๐บ๐ธ USA |
NuVasive NUVA | $1.22 B | 1,770.32% | ๐บ๐ธ USA |
DexCom DXCM | $3.80 B | 5,698.76% | ๐บ๐ธ USA |
AtriCure ATRC | $0.39 B | 508.96% | ๐บ๐ธ USA |